Saman Maleki Vareki
Overview
Explore the profile of Saman Maleki Vareki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cottrell T, Lotze M, Ali A, Bifulco C, Capitini C, Chow L, et al.
J Immunother Cancer
. 2025 Mar;
13(3).
PMID: 40054999
Immunotherapy of cancer is now an essential pillar of treatment for patients with many individual tumor types. Novel immune targets and technical advances are driving a rapid exploration of new...
2.
Heidari M, Maleki Vareki S, Yaghobi R, Karimi M
Front Immunol
. 2024 Oct;
15:1429436.
PMID: 39445008
In the mucosa, T cells and B cells of the immune system are essential for maintaining immune homeostasis by suppressing reactions to harmless antigens and upholding the integrity of intestinal...
3.
Yousefi Y, Baines K, Maleki Vareki S
Cell Rep Med
. 2024 Mar;
5(4):101487.
PMID: 38547865
The gut microbiota influences anti-tumor immunity and can induce or inhibit response to immune checkpoint inhibitors (ICIs). Therefore, microbiome features are being studied as predictive/prognostic biomarkers of patient response to...
4.
Maleki Vareki S, Davar D
Nat Rev Clin Oncol
. 2024 Mar;
21(6):405-406.
PMID: 38509333
No abstract available.
5.
Andary C, Al K, Chmiel J, Gibbons S, Daisley B, Parvathy S, et al.
Trends Mol Med
. 2024 Jan;
30(3):209-222.
PMID: 38195358
Fecal microbiota transplantation (FMT) has emerged as an alternative or adjunct experimental therapy for microbiome-associated diseases following its success in the treatment of recurrent Clostridioides difficile infections (rCDIs). However, the...
6.
Lenehan J, Maleki Vareki S
Genes Immun
. 2023 Dec;
25(1):87-88.
PMID: 38092886
No abstract available.
7.
Routy B, Lenehan J, Miller Jr W, Jamal R, Messaoudene M, Daisley B, et al.
Nat Med
. 2023 Nov;
30(2):604.
PMID: 37923839
No abstract available.
8.
Routy B, Lenehan J, Miller Jr W, Jamal R, Messaoudene M, Daisley B, et al.
Nat Med
. 2023 Jul;
29(8):2121-2132.
PMID: 37414899
Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has...
9.
Gerhardt L, Hong M, Yousefi Y, Figueredo R, Maleki Vareki S
J Immunol
. 2023 Mar;
210(10):1598-1606.
PMID: 37000461
Tumor-specific CD8+ T cells are critical components of antitumor immunity; however, factors that modulate their phenotype and function have not been completely elucidated. Cytokines IL-12 and IL-27 have recognized roles...
10.
Gholami H, Chmiel J, Burton J, Maleki Vareki S
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831641
Not all cancer patients who receive immunotherapy respond positively and emerging evidence suggests that the gut microbiota may be linked to treatment efficacy. Though mechanisms of microbial contributions to the...